Thrombolysis treatment of patients with an acute cerebral infarction: Favourable early results in Maastricht;Trombolyse bij patienten met een acuut herseninfarct: Gunstige eerste ervaringen in Maastricht

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 22, 2000, Pages 1062-1069

  Boiten, J ^a   Wilmink, J T ^a   Lodder, J ^a   Troost, J ^a  

^a Afd Neurologie ^*

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; ANTICOAGULANT AGENT; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL PRACTICE; DRUG EFFECT; FEMALE; HUMAN; MALE; ONSET AGE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DRUG CONTRAINDICATION; FIBRINOLYTIC THERAPY; INJURY SCALE; MIDDLE AGED; NETHERLANDS; NOTE; RADIOGRAPHY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED; TRAUMA SEVERITY INDICES; TREATMENT OUTCOME;

EID: 0034720674     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Koudstaal PJ, Gijn J van. Trombolyse direct na een herseninfarct: quitte of dubbel? Ned Tijdschr Geneeskd 1996;140:2263-5.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
3. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA 1995;274:1017-25.
4. Hacke W, Kaste M, Fieschi C, Von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-51.
5. Stam J, Koudstaal PJ, Franke CL, Kappelle LJ, Boiten J. Trombolyse voor het herseninfarct: het einde van het begin. Ned Tijdschr Geneeskd 2000;144:1028-32.
6. Scholten RJPM, Kostense PJ, Assendelft WJJ, Bouter LM. De praktijk van systematische reviews. IV. Het combineren van de resultaten van afzonderlijke onderzoeken. Ned Tijdschr Geneeskd 1994; 143:786-91.
7. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
8. Grond M, Stenzel C, Schmülling S, Rudolf J, Neveling M, Lechleuthner A, et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29: 1544-9.
9. Trouillas P, Nighoghossian N, Derex L, Adeleine P, Honnorat J, Neuschwander P, et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 1998;29:2529-40.
10. Beusmans GHMI, Velde EVI van de, Wolters CAM, Boiten J. Het transmuraal zorgmodel CVA in de regio Maastricht. Med Contact 1997;52:1314-7.
11. Adams jr HP, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 1996;27:1711-8.
12. Côté R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian neurological scale: a preliminary study in acute stroke. Stroke 1986;17:731-7.
13. Côté R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian neurological scale: validation and reliability assessment. Neurology 1989;39:638-43.
14. Swieten JC van, Koudstaal PJ, Visser MC, Schouten HJA, Gijn J van. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.
15. Barsan WG, Brott TG, Broderick JP, Haley EC, Levy DE, Marler JR. Time of hospital presentation in patients with acute stroke. Arch Intern Med 1993;153:2558-61.
16. Zweifler RM, Brody ML, Graves GC, Drinkard R, Cunningham S, Rothrock JF. Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system. Neurology 1998;50:501-3.
17. Larrue V, Von Kummer R, Del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European cooperative acute stroke study. Stroke 1997; 28:957-60.
18. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28: 2109-18.
19. Von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992;23:646-52.
20. Levy DE, Brott TG, Haley jr EC, Marler JR, Sheppard GL, Barsan W, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994;25:291-7.
21. Del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78-86.
22. Pancioli AM, Broderick J, Kothari R, Brott T, Tuchfarber A, Miller R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998;279:1288-92.
23. Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992;23:352-6.
24. Barsan WG, Brott TG, Broderick JP, Haley jr EC, Levy DE, Marler JR. Urgent therapy for acute stroke. Effects of a stroke trial on untreated patients. Stroke 1994;25:2132-7.
25. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989;91:311-21.
26. Baird AE, Donnan GA, Austin MC, McKay WJ. Early reperfusion in the 'spectacular shrinking deficit' demonstrated by single-photon emission computed tomography. Neurology 1995;45:1335-9.
27. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999;9:193-201.